ACI Logo
Home
Public Seminars
Distance Learning
Career Center
Intelligent Process
Scholarship
War Games
Competitive Intelligence Library
FAQS
Contact Us
Site Map
CI 101 Intelligence Sources & Collection Techniques
Evening Social Networking: Best-in-Class CI Techniques (Eve)
CI 202 Competitive Benchmarking
Evening Ethical Boundaries (Eve)
CI 301 Competitive Blindspots
Evening Communicating CI to Sr. Management (Eve)
CI 302 Cross-Competitor Analysis
Evening CI: The Good, the Bad, and the Ugly (Eve)
CI 303 Creating and Running a World Class Intelligence Operation
CI 401 War Gaming (Theory & Practice) 2 Days
CI 402 Value Chain Analysis
CI 403 Anticipating Disruptions – Scenario Analysis Tools and Techniques
Evening Profit Pool Analysis (Eve)

CI: The Good, the Bad, and the Ugly

Core Certification Course Evening

FACULTY: KALB 0.15 CEU CREDIT

audio
Boston: June 14, October 18

Cliff Kalb, former head of Merck's Global Competitive Intelligence group will have a lively and frank discussion of his own experiences on "CI in the Trenches".

Immediately following course 4 "Cross-Competitor Analysis", Cliff will spend the next hour and a half presenting a no holes-barred discussion of his experiences. You will learn how CI theory is applied in the trenches in a global multinational pharmaceutical company -- the good, the bad and the ugly. Specifically you will learn how to:

  • Grow and mature as a practitioner by learning from mistakes made in a fascinating strategic case history.
  • Break down the steps of a CI assignment into discreet project management tasks.
  • Level set expectations by proper scoping of work and participation in multidisciplinary teams.
  • Minimize fire fighting by pro actively managing the CI producer/consumer relationship
  • Properly prepare KIT's execute against them, deliver insight and close the loop with feedback.
Problem Sets
All ACI programs teach students how to overcome the most challenging competitive intelligence issues. See samples of the problem sets for this course such as:


Enroll Now
iacet scip